Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value.

Preventive oncology is in need of a risk assessment technique that can identify individuals at high risk for breast cancer and has the ability to monitor the efficacy of a risk reducing intervention. Optical transilluminationspectroscopy (OTS) gives information about breast tissue composition and tissue density. OTS is noninvasive and in contrast to mammography, uses nonionizing radiation. It is safe and can be used frequently on younger women, potentially permitting early risk detection and thus increasing the time available for risk reduction interventions to assert their influence. Before OTS can be used as a risk assessment and/or monitoring technique, its predictive ability needs to be demonstrated and maximized through the construction of various mathematical models relating OTS and breast tissue density, and hence, risk. To establish a correlation between OTS and mammographic density principal components analysis (PCA), using risk classification, is calculated. The PCA scores are presented in three-dimensional cluster plots and a plane of differentiation that separates the high and low tissue densities is used to calculate the predictive value. Stratification of PCA for measurement position on the breast in cranial-caudal projection is introduced. Analysis of PCA scores as a function of the volunteer’s age and body mass index (BMI) is examined. A small but significant correlation between the component scores and age or BMI is noted but the correlation is dependent on the tissue density category examined. Correction of the component scores for age and BMI is not recommended, since a priori knowledge of a woman’s breast tissue density is required. Stratification for the center and distal measurement positions provide a predictive value for OTS above 96%.

[1]  Ashleyj . Welch,et al.  Optical-Thermal Response of Laser-Irradiated Tissue , 1995 .

[2]  E. Fishell,et al.  Radio-free America: what to do with the waste. , 1994, Environmental health perspectives.

[3]  M S Patterson,et al.  Optical properties of normal and diseased human breast tissues in the visible and near infrared. , 1990, Physics in medicine and biology.

[4]  J. Wolfe Risk for breast cancer development determined by mammographic parenchymal pattern , 1976, Cancer.

[5]  Albert Cerussi,et al.  Noninvasive functional optical spectroscopy of human breast tissue , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. Tromberg,et al.  Sources of absorption and scattering contrast for near-infrared optical mammography. , 2001, Academic radiology.

[7]  S. J. Graham,et al.  Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. , 1996, British Journal of Cancer.

[8]  Johann Otto,et al.  Spectral transillumination of female breasts and breast tissue-like material , 1995, Other Conferences.

[9]  Alessandro Torricelli,et al.  Four-wavelength time-resolved optical mammograph , 2003, SPIE BiOS.

[10]  M. Ferrari,et al.  Identification and Quantification of Intrinsic Optical Contrast for Near‐infrared Mammography , 1998, Photochemistry and photobiology.

[11]  W. Willett,et al.  Diet, body size, and breast cancer. , 1993, Epidemiologic reviews.

[12]  D. G. Hoel,et al.  ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.

[13]  John L Hopper,et al.  Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. , 2003, Journal of the National Cancer Institute.

[14]  Lothar Lilge,et al.  Validation of self-reported skin color via analysis of diffuse reflectance spectra of skin , 2000, BiOS.

[15]  J. Wolfe,et al.  Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. , 1987, AJR. American journal of roentgenology.

[16]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[17]  A. Mushlin,et al.  Estimating the accuracy of screening mammography: a meta-analysis. , 1998, American journal of preventive medicine.

[18]  F. Harder,et al.  Prophylactic mastectomy--evaluation and treatment of high risk patients. , 2002, Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera.

[19]  J Whitehead,et al.  The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. , 1985, American journal of epidemiology.

[20]  J. Wolfe Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.

[21]  S. Lakhani,et al.  Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. , 2000, Journal of biomedical optics.

[22]  T. Julian,et al.  Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. , 2001, Cytometry.

[23]  F Merletti,et al.  Mammographic features of the breast and breast cancer risk. , 1982, American journal of epidemiology.

[24]  N. Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  P. Stomper,et al.  Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. , 1996, AJR. American journal of roentgenology.

[26]  R N Hoover,et al.  Mammographic densities and risk of breast cancer , 1991, Cancer.

[27]  Gina Rollins Tamoxifen and raloxifene may benefit women at high risk for breast cancer. , 2002, Report on medical guidelines & outcomes research.

[28]  R L Egan,et al.  Optical Spectroscopy , 1988, Acta radiologica.

[29]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.